MEDNAX Inc
NYSE:MD
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6.77
16.08
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MD stock under the Base Case scenario is 23.48 USD. Compared to the current market price of 14.96 USD, MEDNAX Inc is Undervalued by 36%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
MEDNAX Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
MEDNAX Inc
Balance Sheet Decomposition
MEDNAX Inc
Current Assets | 528.2m |
Cash & Short-Term Investments | 220.5m |
Receivables | 288.1m |
Other Current Assets | 19.7m |
Non-Current Assets | 1.5B |
PP&E | 98.5m |
Intangibles | 1.3B |
Other Non-Current Assets | 198m |
Current Liabilities | 373.1m |
Accounts Payable | 47.4m |
Accrued Liabilities | 303.1m |
Other Current Liabilities | 22.6m |
Non-Current Liabilities | 971.3m |
Long-Term Debt | 607.4m |
Other Non-Current Liabilities | 363.9m |
Earnings Waterfall
MEDNAX Inc
Revenue
|
2B
USD
|
Operating Expenses
|
-1.8B
USD
|
Operating Income
|
164.6m
USD
|
Other Expenses
|
-418.5m
USD
|
Net Income
|
-253.8m
USD
|
Free Cash Flow Analysis
MEDNAX Inc
USD | |
Free Cash Flow | USD |
MD Profitability Score
Profitability Due Diligence
MEDNAX Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
MEDNAX Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
MD Solvency Score
Solvency Due Diligence
MEDNAX Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
MEDNAX Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MD Price Targets Summary
MEDNAX Inc
According to Wall Street analysts, the average 1-year price target for MD is 15.89 USD with a low forecast of 13.13 USD and a high forecast of 18.9 USD.
Dividends
Current shareholder yield for MD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
MD Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
MEDNAX, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,725 full-time employees. The firm provides neonatal care, which provides clinical care to babies born prematurely or with complications within specific units at hospitals, primarily neonatal intensive care units (NICUs), through its network of affiliated neonatal physician subspecialists (neonatologists), neonatal nurse practitioners and other pediatric clinicians. The company offers maternal-fetal care, which provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians, such as maternal-fetal nurse practitioners and certified nurse mid-wives. The company provides other pediatric subspecialty care services, which includes other pediatric subspecialists, such as, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists.
Contact
IPO
Employees
Officers
The intrinsic value of one MD stock under the Base Case scenario is 23.48 USD.
Compared to the current market price of 14.96 USD, MEDNAX Inc is Undervalued by 36%.